首页> Ophthalmology and therapy> Real-World Cost Savings Demonstrated by Switching Patients with Refractory Diabetic Macular Edema to Intravitreal Fluocinolone Acetonide (Iluvien): A Retrospective Cost Analysis Study.

Real-World Cost Savings Demonstrated by Switching Patients with Refractory Diabetic Macular Edema to Intravitreal Fluocinolone Acetonide (Iluvien): A Retrospective Cost Analysis Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Soon W,Ch'ng

第一单位： Department of Ophthalmology, Leicester Royal Infirmary, Infirmary Square, Leicester, UK.

作者： Soon W,Ch'ng ^[1] ; Alexander J,Brent ^[2] ; Theodoros,Empeslidis ^[1] ; Vasileios,Konidaris ^[1] ; Somnath,Banerjee ^[1]

作者单位： Department of Ophthalmology, Leicester Royal Infirmary, Infirmary Square, Leicester, UK. ^[1] Department of Ophthalmology, Leicester Royal Infirmary, Infirmary Square, Leicester, UK. ajb101@doctors.org.uk. ^[2]

关键词 Cost DME Diabetic macular edema FAc Financial Fluocinolone acetonide Iluvien

DOI 10.1007/s40123-017-0114-6

PMID 29127657

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览5

Ophthalmology and therapy

2018年7卷1期

75-82页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览5

点击下载本期目录封面

Ophthalmology and therapy

2018年7卷1期

75-82页

检索历史清除

Real-World Cost Savings Demonstrated by Switching Patients with Refractory Diabetic Macular Edema to Intravitreal Fluocinolone Acetonide (Iluvien): A Retrospective Cost Analysis Study.

Ophthalmology and therapy

相似文献

同项目论文

Ophthalmology and therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Real-World Cost Savings Demonstrated by Switching Patients with Refractory Diabetic Macular Edema to Intravitreal Fluocinolone Acetonide (Iluvien): A Retrospective Cost Analysis Study.

Ophthalmology and therapy

相似文献

同项目论文

Ophthalmology and therapy

相关期刊

检索历史清除